“…The monoclonal antibody d2-40 recognizes the membrane 40 kd sialoglycoprotein podoplanin. Podo pla nin is an established marker for germ cell tumours, mesotheliomas, Kaposi sarcoma, lymphovascular tumours, hemangioendothelioma, schwannoma, some skin tumours (Kalof and Cooper, 2009), dermatofibroma (Kaddu and Leinweber, 2009), epithelioid sarcoma (Karagkounis et al, 2013) and ependymoma (Ishizawa et al, 2009). It is also expressed in a variety of normal cells including lymphatic endothelial cells, follicular dendritic cells (Marsee et al, 2009) and myoepithelial cells of the breast (Kanner et al, 2010), chondrocytes and osteocytes (Ariizumi et al, 2010).…”